NCT00099801已完成3 期
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
研究概览
简要总结
The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing their first kidney transplant
- •Male or female age 18 to 65 years
排除标准
- •Patients in need of second kidney transplant or multi-organ transplants.
研究者
相似试验
已完成
2 期
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney TransplantKidney TransplantationNCT00099749Novartis Pharmaceuticals255
已完成
3 期
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantKidney TransplantationNCT00099736Novartis Pharmaceuticals696
已完成
3 期
Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantationKidney TransplantationNCT00098735Novartis Pharmaceuticals140
撤回
2 期
Study of FTY720 in Patients With UveitisAcute Noninfectious Posterior, Intermediate, or Pan UveitisNCT01791192Novartis Pharmaceuticals
已完成
2 期
Efficacy and Safety of FTY720 for Acute StrokeVascular AccidentStrokeIschemic Cerebrovascular AccidentStroke, AcuteCerebral StrokeNCT02002390Tianjin Medical University General Hospital22